Functional characterization and structural modeling of obesity associated mutations in the melanocortin 4 receptor.
Mutations in the melanocortin 4 receptor (MC4R) gene are the most common known cause of monogenic human obesity. The MC4R gene was sequenced in 2000 subjects with severe early-onset obesity. We detected seven different nonsense and 19 nonsynonymous mutations in a total of 94 probands, some of which have been reported previously by others. We functionally characterized the 11 novel obesity associated missense mutations. Seven of these mutants (L54P, E61K, I69T, S136P, M161T, T162I, and I269N) showed impaired cell surface trafficking, reduced level of maximal binding of the radioligand [125I]NDP-MSH, and reduced ability to generate cAMP in response to ligand. Four mutant MC4Rs (G55V, G55D, S136F, and A303T) displayed cell surface expression and agonist binding similar to the wild-type receptor but showed impaired cAMP production, suggesting that these residues are likely to be critical for conformational rearrangement essential for receptor activation. Homology modeling of these mutants using a model of MC4R based on the crystal structure of the beta2-adrenoreceptor was used to provide insights into the possible structural basis for receptor dysfunction. Transmembrane (TM) domains 1, 3, 6, 7, and peripheral helix 8 appear to participate in the agonist-induced conformational rearrangement necessary for coupling of ligand binding to signaling. We conclude that G55V, G55D, S136F, and A303T mutations are likely to strengthen helix-helix interactions between TM1 and TM2, TM3 and TM6, and TM7 and helix 8, respectively, preventing relative movement of these helices during receptor activation. The combination of functional studies and structural modeling of naturally occurring pathogenic mutations in MC4R can provide valuable information regarding the molecular mechanism of MC4R activation and its dysfunction in human disease.
Tan
Karen
K
University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke's Hospital, Box 289, Hills Road, Cambridge CB2 2QQ, United Kingdom.
Pogozheva
Irina D
ID
Yeo
Giles S H
GS
Hadaschik
Dirk
D
Keogh
Julia M
JM
Haskell-Leuvano
Carrie
C
O'Rahilly
Stephen
S
Mosberg
Henry I
HI
Farooqi
I Sadaf
IS
D017668:Age of Onset; D000595:Amino Acid Sequence; D019943:Amino Acid Substitution; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism; D005786:Gene Expression Regulation; D006801:Humans; D051379:Mice; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation; D020125:Mutation, Missense; D009765:Obesity / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011487:Protein Conformation; D044105:Receptor, Melanocortin, Type 4 / Q000737:chemistry / Q000235:genetics*; D015027:Zebrafish; D029961:Zebrafish Proteins / Q000737:chemistry / Q000235:genetics
C470072:MC4R protein, human; D044105:Receptor, Melanocortin, Type 4; D029961:Zebrafish Proteins; C461479:mc4r protein, zebrafish; D000242:Cyclic AMP
Biochemistry. 2007 Jul 17;46(28):8273-87
17590021
J Clin Endocrinol Metab. 1995 Jan;80(1):65-71
7829641
Science. 2007 Nov 23;318(5854):1266-73
17962519
Science. 2007 Nov 23;318(5854):1258-65
17962520
Endocrinology. 2008 Apr;149(4):1935-41
18162519
Nat Rev Drug Discov. 2008 Apr;7(4):339-57
18382464
Diabetes. 2008 Sep;57(9):2511-8
18559663
Mol Endocrinol. 1997 Nov;11(12):1806-13
9369448
J Biol Chem. 1998 Sep 11;273(37):24196-206
9727043
Arch Dis Child. 1995 Jul;73(1):25-9
7639544
Diabetes. 1999 Mar;48(3):635-9
10078568
J Clin Endocrinol Metab. 1999 Apr;84(4):1483-6
10199800
Biochemistry. 2004 Dec 21;43(50):15796-810
15595835
Biochemistry. 2005 Mar 8;44(9):3418-31
15736952
Nat Neurosci. 2005 May;8(5):571-8
15856065
Mol Cell Endocrinol. 2005 Jul 15;239(1-2):1-14
15975705
Biochemistry. 2005 Aug 30;44(34):11329-41
16114870
Peptides. 2005 Oct;26(10):1909-19
16083993
Chem Biol Drug Des. 2006 Mar;67(3):215-29
16611215
J Clin Endocrinol Metab. 2006 May;91(5):1811-8
16507637
Biochemistry. 2006 Jun 13;45(23):7277-88
16752916
Nat Rev Mol Cell Biol. 2006 Oct;7(10):727-38
16990852
J Biol Chem. 2006 Nov 10;281(45):34561-73
16959776
Mamm Genome. 2006 Dec;17(12):1162-71
17143585
Hum Mutat. 2007 Mar;28(3):294-302
17072869
Exp Clin Endocrinol Diabetes. 2007 Jan;115(1):7-12
17286227
BioDrugs. 2007;21(3):157-66
17516711
Science. 2000 Aug 4;289(5480):739-45
10926528
Clin Endocrinol (Oxf). 2001 Apr;54(4):493-8
11318785
J Biol Chem. 2002 Jan 18;277(3):2247-57
11698401
EMBO J. 2002 Apr 2;21(7):1628-37
11927547
J Mol Med (Berl). 2002 May;80(5):267-9
12021837
J Mol Med (Berl). 2002 Jul;80(7):406-11
12110946
Hum Mol Genet. 2003 Mar 1;12(5):561-74
12588803
Endocrinology. 2003 Apr;144(4):1301-14
12639913
N Engl J Med. 2003 Mar 20;348(12):1085-95
12646665
Biochemistry. 2003 Apr 8;42(13):3708-15
12667061
J Biol Chem. 2003 Jun 20;278(25):22939-45
12690102
Diabetes. 2003 Dec;52(12):2984-8
14633860
Biochem J. 2003 Dec 15;376(Pt 3):595-605
14531729
J Med Genet. 2004 Feb;41(2):e13
14757863
Biochemistry. 1995 Nov 28;34(47):15407-14
7492540
Mol Cell Endocrinol. 1997 Apr 4;128(1-2):171-7
9140088
J Clin Invest. 2004 Oct;114(8):1158-64
15489963
Biophys J. 1992 Apr;62(1):107-9
1600090
Hum Mol Genet. 2007 Sep 15;16(18):2249-60
17616515